Article
Identification of Germline Cancer Predisposition Variants During Clinical Ctdna Testing
2021-03-02
Abstract excerpt
Next-generation sequencing (NGS) of circulating tumor DNA (ctDNA) is a non-invasive method to guide therapy selection for cancer patients. ctDNA variant allele frequency (VAF) is commonly reported and may aid in discerning whether a variant is germline or somatic. We report on the fidelity of VAF in ctDNA as a predictor for germline variant carriage. Two patient cohorts were studied. Cohort 1 included patients wit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7b12d520-3603-593c-b7b7-5c6df0506ad3
- DOI
- 10.21203/rs.3.rs-256641/v1
